Rosiglitazone Induces Decreases in Bone Mass and Strength that Are Reminiscent of Aged Bone
Open Access
- 1 June 2007
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 148 (6), 2669-2680
- https://doi.org/10.1210/en.2006-1587
Abstract
PPARγ regulates both glucose metabolism and bone mass. Recent evidence suggests that the therapeutic modulation of PPARγ activity with anti-diabetic thiazolidinediones elicits unwanted effects on bone. In this study, the effects of rosiglitazone on the skeleton of growing (1 month), adult (6 month), and aged (24 month) C57BL/6 mice were determined. Aging was identified as a confounding factor for rosiglitazone-induced bone loss that correlated with the increased expression of PPARγ in bone marrow mesenchymal stem cells. The bone of young growing mice was least affected, although a significant decrease in bone formation rate was noted. In both adult and aged animals bone volume was significantly decreased by rosiglitazone. In adult animals bone loss correlated with attenuated bone formation, whereas in aged animals bone loss was associated with increased osteoclastogenesis, mediated by increased RANKL expression. PPARγ activation led to changes in marrow structure and function such as a decrease in osteoblast number, an increase in marrow fat cells, an increase in osteoclast number, and a loss of the multipotential character of marrow mesenchymal stem cells. In conclusion, rosiglitazone induces changes in bone reminiscent of aged bone and appears to induce bone loss by altering the phenotype of marrow mesenchymal stem cells.Keywords
This publication has 42 references indexed in Scilit:
- Activation of Peroxisome Proliferator-Activated Receptor γ (PPARγ) by Rosiglitazone Suppresses Components of the Insulin-Like Growth Factor Regulatory System in Vitro and in VivoEndocrinology, 2007
- Thiazolidinedione Use and Bone Loss in Older Diabetic AdultsJournal of Clinical Endocrinology & Metabolism, 2006
- Parathyroid Hormone Controls Receptor Activator of NF-κB Ligand Gene Expression via a Distant Transcriptional EnhancerMolecular and Cellular Biology, 2006
- Activation of Receptor Activator of NF-κB Ligand Gene Expression by 1,25-Dihydroxyvitamin D3 Is Mediated through Multiple Long-Range EnhancersMolecular and Cellular Biology, 2006
- Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fatBone, 2006
- Mesenchymal stem cell agingExperimental Gerontology, 2005
- The Many Faces of PPARγCell, 2005
- Aging Increases Stromal/Osteoblastic Cell-Induced Osteoclastogenesis and Alters the Osteoclast Precursor Pool in the MouseJournal of Bone and Mineral Research, 2005
- Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Association of Bone Mineral Density with a Polymorphism of the Peroxisome Proliferator-Activated Receptor γ Gene: PPARγ Expression in OsteoblastsBiochemical and Biophysical Research Communications, 1999